OBSCN-IGSF21 Fusion FISH Probe
The OBSCN-IGSF21 Fusion FISH Probe is used to confirm a fusion of the OBSCN and IGSF21 genes. The fusion of the OBSCN and IGSF21 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| OBSCN-IGSF21-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-RERE | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-REOR | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-REGO | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-REGR | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-OROR | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-GORE | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-GROR | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| OBSCN-IGSF21-20-AQAQ | 20 (40 μL) | 200 μL |
|
OBSCN Gene Summary
The obscurin gene spans more than 150 kb, contains over 80 exons and encodes a protein of approximately 720 kDa. The encoded protein contains 68 Ig domains, 2 fibronectin domains, 1 calcium/calmodulin-binding domain, 1 RhoGEF domain with an associated PH domain, and 2 serine-threonine kinase domains. This protein belongs to the family of giant sacromeric signaling proteins that includes titin and nebulin, and may have a role in the organization of myofibrils during assembly and may mediate interactions between the sarcoplasmic reticulum and myofibrils. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Gene Name: Obscurin, Cytoskeletal Calmodulin And Titin-interacting RhoGEF
Chromosome: CHR1: 228395860 -228566575
Locus: 1q42.13
IGSF21 Gene Summary
This gene encodes a protein which has two immunoglobulin (Ig) domains and is a member of the immunoglobulin superfamily. Proteins in this superfamily are usually found on or in cell membranes and act as receptors in immune response pathways. [provided by RefSeq, Sep 2011]
Gene Name: Immunoglobin Superfamily Member 21
Chromosome: CHR1: 18434239 -18704977
Locus: 1p36.13
Gene Diseases
The OBSCN IGSF21 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|